Fertility Awareness Effectiveness

Validating ovulation prediction and confirmation with the Mira monitor: blinded ultrasound and serum hormone comparison

Bouchard TP, Bedaiwy M, Talhouk A, Nakhuda G, Yong PJ, Doyle-Baker PK

Published July 18, 2026 Reproductive biomedicine online
DOI 10.1016/j.rbmo.2026.105881 PMID 42600546

RRM Academy Synopsis

Mira urinary LH peak closely matched ovulation in regular cycles

A 2026 blinded diagnostic accuracy study of 52 women with regular cycles reports that the Mira monitor's urinary luteinizing hormone (LH) peak day closely matched the ovulation day seen on ultrasound. In 96% of ovulations the two days differed by plus or minus 1 day at most.

Key Findings

  • Blood and first-morning urine hormones correlated significantly when collected within 90 minutes (LH: R² = 0.92; estrone-3-glucuronide: R² = 0.73; follicle stimulating hormone: R² = 0.61; pregnanediol glucuronide: R² = 0.75).
  • A rise in pregnanediol glucuronide (PDG) on the Mira monitor was also strongly associated with the day of ovulation seen on ultrasound (R² = 0.87, P < 0.001).
  • Among the participants with regular cycles, 11% had anovulatory cycles, meaning cycles without ovulation.
  • The day of the LH peak on the Mira monitor was a strong predictor of ultrasound-confirmed ovulation day (R² = 0.96, P < 0.001; intraclass correlation coefficient = 0.971).

Interpretation

This synopsis rests on the published abstract, and the full text was not reviewed. The work is a prospective, single-center, blinded diagnostic accuracy study. Women aged 19-44 years with cycles of 24-38 days tracked 153 cycles over 18 months, and 890 serial transvaginal ultrasound scans identified the ovulation day. The final analysis used 121 ovulatory cycles from 49 participants. The authors conclude that the Mira monitor predicts and confirms ovulation accurately in these women with regular cycles.

RRM Context

RRM treats the ovulatory cycle as a vital sign, since ovulation leads to progesterone production. Urine hormone tests checked against ultrasound show how well cycle monitoring finds ovulation. Work of this kind gives cycle-based care a measured link between a home test and the ovary itself.

Abstract

Research Question

Do quantitative urinary hormone measurements on the Mira monitor predict and confirm ovulation accurately compared with ultrasound in women with regular menstrual cycles? Do Mira urine hormones correlate with serum hormones?

Design

This was a prospective, single-centre, blinded diagnostic accuracy study with 52 women aged 19-44 years with regular cycles (24-38 days) who tracked 153 cycles over 18 months. Daily first-morning urine was tested with the Mira monitor for follicle stimulating hormone (FSH), oestrone-3-glucuronide (E13G), luteinizing hormone (LH) and pregnanediol glucuronide (PDG). Serial transvaginal ultrasounds (890 scans) confirmed the day of ovulation. Serum hormones were measured twice per cycle. The 121 ovulatory cycles from 49 participants with sufficient index test and reference standard data were included in the final analysis.

Results

The Mira LH peak day strongly predicted ultrasound-confirmed ovulation (R² = 0.96, P < 0.001; intraclass correlation coefficient = 0.971), with 96% of ovulations occurring within ±1 day. The Mira PDG increase was also strongly associated with ultrasound-confirmed day of ovulation (R² = 0.87, P < 0.001). First-morning urine hormones were significantly associated with serum hormones when collected within 90 min (LH: R² = 0.92; E13G: R² = 0.73; FSH: R² = 0.61; PDG: R² = 0.75). Anovulatory cycles were identified in 11% of regularly cycling participants.

Conclusions

Quantitative urinary hormone monitoring with the Mira monitor provides accurate prediction and confirmation of ovulation, with strong urine-serum associations supporting reduced reliance on serial serum draws in select patients. These findings support clinical adoption of quantitative urinary fertility monitoring.

Read the guide

  • Fertility Awareness Methods Compared

    Clinician-reviewed comparison of fertility awareness-based methods (Billings, Creighton, Sensiplan, Marquette, Standard Days, apps). Every effectiveness figure cited and labeled by metric.

    30 min read

Topics

By this author

Related research

Fertility Awareness › Effectiveness › Comparative Effectiveness · Menstrual Cycle › Cycle Biomarkers › Hormonal Markers · Reproductive Endocrinology › Ovulation Physiology › Anovulation
Thomas P Bouchard, Mohamed Bedaiwy, Aline Talhouk, Gary Nakhuda, Paul J Yong, Patricia K Doyle-Baker
Tom Bouchard, T Bouchard, M Bedaiwy, A Talhouk, G Nakhuda, P Yong, Pat Doyle-Baker, Trish Doyle-Baker, P Doyle-Baker
PMID 42600546 42600546 DOI 10.1016/j.rbmo.2026.105881 10.1016/j.rbmo.2026.105881 Bouchard et al. 2026, Bouchard 2026